Delivery Order SPE2DB22D2006-SPE2DB25FV7QC

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,271.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a performance period ending on April 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,963.79 firm-fixed-price delivery order is for the supply of 4564766697 ONFI 10 MG TABLET 100S, a pharmaceutical product. The ultimate completion date for this contract is June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,872.23 firm fixed-price delivery order is for the supply of 4567296220 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order with a ceiling value of $9,208.60, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567678960 ! ONFI 10 MG TABLET 100S, with an ultimate completion date of March 25, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a Firm Fixed Price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $6,723.92 contract is for the supply of 4564604898 - ONFI 10 MG TABLET 100S, a pharmaceutical product. The order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,065.04 firm fixed price delivery order covers the supply of 4566860013 - ONFI 10 MG TABLET 100S, with a performance period ending on January 8, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567394741 ONFI 10 MG TABLET 100S, with a ceiling value of $2,008.80 and a completion date of February 27, 2025. The contract is a Firm Fixed Price (FFP) instrument, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,526.60 firm fixed-price delivery order is for the supply of 4566743308 ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,399.48, is for the delivery of 4567684697 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,777.42 Firm Fixed Price Delivery Order contract is for the supply of 4567361471 - ONFI 10 MG TABLET 100S, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7QC
    Delivery Order

This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566927608 - ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $3,683.44 and a performance period through January 15, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 4/16/25, 6:11 PM